{"title": "Estudio de la incidencia de enfermedad neumoc\u00f3cica invasora entre 0\u20135 a\u00f1os en el Pa\u00eds Vasco y Navarra | Anales de Pediatr\u00eda", "author": "Bernaola Iturbe; E; De Aristegui Fern\u00e1ndez; J; Herranz Aguirre; M; Garc\u00eda Calvo; C; Fern\u00e1ndez P\u00e9rez", "url": "http://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-resumen-S1695403302779319", "hostname": "analesdepediatria.org", "description": "AntecedentesStreptococcus pneumoniae es la causa m\u00e1s frecuente de bacteriemia y neumon\u00eda y", "sitename": "Anales de Pediatr\u00eda", "date": "2002-10-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Streptococcus pneumoniae es la causa m\u00e1s frecuente de bacteriemia y neumon\u00eda y la segunda causa de meningitis bacteriana en la edad pedi\u00e1trica.Objetivo\nEstablecer la incidencia, las caracter\u00edsticas y los serotipos predominantes de enfermedad neum\u00f3nica invasora (ENI) en ni\u00f1os menores de 5 a\u00f1os en 2 comunidades ut\u00f3nomas:Pa\u00eds Vasco y Navarra. El per\u00edodo de estudio comprendi\u00f3del 31 de mayo de 1998 al 1 de junio de 2001.Pacientes y m\u00e9todos\nEstudio descriptivo, observacional y retrospectivo. La poblaci\u00f3n de estudio incluy\u00f3 a los ni\u00f1os diagnosticados de ENI en los hospitales p\u00fablicos y privados con servicio de pediatr\u00eda. Se defini\u00f3 la ENI por el aislamiento de S. pneumonia en hemocultivo, l\u00edquido cefalorraqu\u00eddeo (LCR) u otros sitios est\u00e9riles. Se revisaron las historias cl\u00ednicas y se analizaron las caracter\u00edsticas demogr\u00e1ficas y diagn\u00f3sticas. Se establecieron las frecuencias ajustadas por edades de ambas \u00e1reas, mediante estandarizaci\u00f3n directa. Los intervalos de confianza (IC) de las frecuencias se obtuvieron por la distribuci\u00f3n de Poisson. Se utilizaron los paquetes inform\u00e1ticos SPSS para Windows 10.0 y Epidat 2.1. Se emple\u00f3 la revisi\u00f3n poblacional del padr\u00f3n municipal de 1999.Resultados\nSe incluyeron 171 ni\u00f1os con edades entre 0 y 5 a\u00f1os. El 40,9% (70 ni\u00f1os) eran menores de 12 meses y el 68,4% (117 ni\u00f1os) entre 0 y 2 a\u00f1os y predominaban los varones. El 16,4% hab\u00edan recibido antibioticoterapia previa al diagn\u00f3stico. Las formas de presentaci\u00f3n m\u00e1s frecuentes fueron bacteriemia oculta (45,6 %), neumon\u00eda bacteri\u00e9mica (27,5 %) y meningitis (14,6 %). Las complicaciones m\u00e1s frecuentes fueron las respiratorias, con derrame pleural en el 23 % de las neumon\u00edas. La incidencia anual estandarizada de ENI (casos por cada 100.000) en los ni\u00f1os entre 0 y 59 meses fue de 58,82 (IC 95 %, 27,99\u201389,65) en Navarra y de 55,35 casos (IC 95 %, 38,81\u201371,88) en el Pa\u00eds Vasco. En el caso de ni\u00f1os entre 0 y 23 meses se observaron globalmente 93,49 casos/a\u00f1o/100.000 ni\u00f1os (IC 95 %, 77,32\u2013 112,04) y en los ni\u00f1os entre 0 y 11 meses se alcanzaron los 110,21 casos/a\u00f1o/100.000 ni\u00f1os (IC 95 %, 85,91\u2013139,24). La incidencia de meningitis y bacteriemia en los ni\u00f1os entre 0 y 23 meses fue de 15,98 (IC 95 %, 9,76\u201324,68) y 51,14 (IC 95 %, 39,38-65,30) casos/a\u00f1o/100.000 ni\u00f1os, respectivamente. Se serotipificaron 59 cepas, y los serotipos/serogrupos m\u00e1s frecuentes fueron el 1, 4, 6B, 14, 18C, 19 y 23F. El 52,15 % de las cepas fueron sensibles a penicilina y el 93 % a cefotaxima. Los serotipos/serogrupos m\u00e1s resistentes fueron el 6B, 14, 19, 23F y 35.Conclusi\u00f3n\nLa incidencia observada en este estudio es similar a la reportada en otros pa\u00edses, como Estados Unidos, y superior a la comunicada en el resto de Europa. La cobertura de la vacuna es similar a la descrita en otros art\u00edculos.\nStreptococcus pneumoniae is the most commonly reported bacterial cause of bacteremia and bacteremic pneumonia and the second most frequent cause of meningitis.Objective\nTo establish the incidence, characteristics and serotypes causing invasive pneumococcal disease in children aged less than 5 years in two Autonomous Communities in Spain, the Basque country and Navarre, between 31 May 1988 and 1 June 2001.Patients and methods\nWe performed a descriptive, observational and retrospective study. The study population was composed of children diagnosed with invasive pneumococcal disease in the public and private hospitals with a pediatrics departments. Invasive pneumococcal disease was defined as isolation of S. pneumoniae in blood, cerebrospinal fluid or any other sterile biological fluid. Medical records were reviewed and demographic and diagnostic variables were analyzed. Age-adjusted frequency rates were established for both regions using direct standardization. Confidence intervals were obtained by Poisson distribution. SPSS for Windows 10.0 and Epidat 2.1 were used for the analysis. Data were obtained from the 1999 municipal population census.Results\nOne hundred seventy-one children aged 0\u20135 years wereincluded. A total of 40.9% (70 patients) were aged less than12 months and 68.4 % were aged 0\u20132 years; 16.4 % had receiveddrug therapy before diagnosis. The most commonforms of presentation were occult bacteremia (45.6 %), bacteremicpneumonia (27.5 %) and meningitis (14.6 %). Themost frequent complications involved the respiratory tract,with pleural effusion in 23 % of cases of pneumonia. Thestandardized annual incidence rate of invasive pneumococcaldisease (cases per 100,000) in children aged 0\u201359 monthswas 58.82 (95 % CI: 27.99\u201389.65) in Navarre and 55.35 (95%CI: 38.81\u201371.88) in the Basque Country. In children aged 0\u201323 months, the overall incidence was 93.49 cases per100,000 children (95% CI: 77.32\u2013112.04) and in infants aged 0\u201311 months, it was 110,21 cases per 100,000 children (95%CI: 85.91\u2013139.24). The incidence rates for meningitis andbacteremia in children aged 0\u201323 months was 15.98 (95%CI: 9.76\u201324.68) and 51.14 (95 % IC: 39.38\u201365.30) cases per100.000 children. Fifty-nine strains were serotyped. Themost frequent serotypes/groups were 1, 4, 6B, 14, 18C,19 and 23F. A total of 52.15 % of the serotypes were penicillin-susceptible and 93 % were cefotaxime-susceptible.The serotypes/groups with the highest rates of resistancewere 6B, 14,19, 23F and 35.Conclusion\nOur incidence rates are similar to those observed in othercountries such as the United States and are higher thanthose reported for the rest of Europe. Vaccine coverage issimilar to that described in other articles.\n[[1.]] [[2.]] [[3.]] [[4.]] [[5.]] [[6.]] [[7.]] [[8.]] [[9.]] [[10.]] [[11.]] [[12.]] [[13.]] [[14.]] [[15.]] [[16.]] [[17.]] [[18.]] [[19.]] [[20.]] [[21.]] [[22.]]\nTrabajo promovido y financiado por Laboratorios Wyeth-Farma.", "language": null, "image": "https://multimedia.elsevier.es/PublicationsMultimediaV1/revista/cover/16954033?idApp=UINPBA00005H", "pagetype": "article", "links": ["https://tienda.elsevier.es/anales-de-pediatria-16954033.html", "/", "es-busqueda-avanzada", "/es-compartir-twitter?item=S1695403302779319", "/es-compartir-facebook?item=S1695403302779319", "/es-compartir-linkedin?item=S1695403302779319", "whatsapp://send?text=http://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-resumen-S1695403302779319", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Estudio%20de%20la%20incidencia%20de%20enfermedad%20neumoc%C3%B3cica%20invasora%20entre%200%E2%80%935%20a%C3%B1os%20en%20el%20Pa%C3%ADs%20Vasco%20y%20Navarra&body=https://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-S1695403302779319", "/es-guia-autores", "/es-compartir-twitter?item=S1695403302779319", "/es-compartir-facebook?item=S1695403302779319", "/es-compartir-linkedin?item=S1695403302779319", "whatsapp://send?text=http://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-resumen-S1695403302779319", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Estudio%20de%20la%20incidencia%20de%20enfermedad%20neumoc%C3%B3cica%20invasora%20entre%200%E2%80%935%20a%C3%B1os%20en%20el%20Pa%C3%ADs%20Vasco%20y%20Navarra&body=https://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-S1695403302779319", "es-busqueda-avanzada", "/es-vol-57-num-4-sumario-S1695403302X74906", "/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-S1695403302779319", "/es", "/es-ahead-of-print", "/es-vol-99-num-3-sumario-S1695403323X00071", "/es-numeros-anteriores", "/es-suplementos", "/es-alerta-email", "/es-guia-autores", "/es-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/es-diversity-pledge", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/c_i_es.pdf", "/es-acerca-revista", "/es-comite-editorial", "https://tienda.elsevier.es/anales-de-pediatria-16954033.html", "mailto:analespediatria@elsevier.com", "/es-contratar", "/es-mas-leidos", "/es-mas-citado", "/es-mas-populares", "/es-metricas", "https://multimedia.elsevier.es/PublicationsMultimediaV1/revista/cover/16954033?idApp=UINPBA00005H", "/es-rss-ultimo", "https://tienda.elsevier.es/anales-de-pediatria-16954033.html", "/es-metricas#factorimpacto", "/es-metricas#citescore", "/es-metricas#sjr", "/es-metricas#snip", "/es-metricas", "/es-meningitis-neumococica-ninos-espanoles-incidencia-articulo-S1695403302779307", "/es-factores-predictivos-enfermedad-neumococica-invasora-articulo-S1695403302779320", "/es-vol-57-num-4-sumario-S1695403302X74906", "/es-exportar-rif-S1695403302779319", "/es-compartir-twitter?item=S1695403302779319", "/es-compartir-facebook?item=S1695403302779319", "/es-compartir-linkedin?item=S1695403302779319", "whatsapp://send?text=http://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-S1695403302779319", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Estudio%20de%20la%20incidencia%20de%20enfermedad%20neumoc%C3%B3cica%20invasora%20entre%200%E2%80%935%20a%C3%B1os%20en%20el%20Pa%C3%ADs%20Vasco%20y%20Navarra&body=https://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-S1695403302779319", "javascript:imprimirItem()", "/es-pdf-S1695403302779319", "/es-epub-S1695403302779319", "/es-estadisticas-S1695403302779319", "/es-vol-57-num-4-sumario-S1695403302X74906", "/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-S1695403302779319", "/index.php?p=revista&tipo=pdf-simple&pii=S1695403302779319", "#aff0005", "#aff0010", "#aff0005", "mailto:bernaola@teleline.es", "#aff0015", "#aff0020", null, null, null, null, "/es-estadisticas-S1695403302779319", "/es-estadisticas-S1695403302779319", "/es-pdf-S1695403302779319", null, null, "http://dx.doi.org/10.1086/317924", "https://www.ncbi.nlm.nih.gov/pubmed/11120930", null, null, null, null, "https://www.ncbi.nlm.nih.gov/pubmed/11277827", null, "/index.php?p=doi-resolver&doi=10.1016/S0140-6736(00)04222-7", "https://www.ncbi.nlm.nih.gov/pubmed/11289365", null, null, null, null, null, null, null, "https://www.ncbi.nlm.nih.gov/pubmed/11840082", null, null, null, "https://www.ncbi.nlm.nih.gov/pubmed/11792262", null, null, null, null, "https://www.ncbi.nlm.nih.gov/pubmed/10749457", null, "http://dx.doi.org/10.1056/NEJM200102083440602", "https://www.ncbi.nlm.nih.gov/pubmed/11172176", null, null, "https://www.ncbi.nlm.nih.gov/pubmed/11740313", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/Recomendaciones_pediatricas_Covid1.pdf?6", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/doc_posicionamiento.pdf", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/SIM-PedS.pdf", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/Recomendaciones_pediatricas_Covid2.pdf?2", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/manejo_pediatrico_covid.pdf?2", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/reanimacion_cardiopulmonar_pediatrica_covid.pdf", "/es-obituario-quero-jimenez", "/es-analisis-funcion-pancreatica-pacientes-pediatricos-avance-S169540332200145X?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/es-asociacion-entre-el-tiempo-pantalla-avance-S1695403322001308?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/es-reduccion-tasa-incidencia-bronquiolitis-aguda-articulo-S1695403321002642?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/es-derrame-pleuropulmonar-tuberculoso-epoca-covid-19-articulo-S1695403321001995?esCovid=Dr56DrLjUdaMjzAgze452SzSInMN&rfr=truhgiz&y=kEzTXsahn8atJufRpNPuIGh67s1", "/es-covid", "javascript:imprimirItem()", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Estudio%20de%20la%20incidencia%20de%20enfermedad%20neumoc%C3%B3cica%20invasora%20entre%200%E2%80%935%20a%C3%B1os%20en%20el%20Pa%C3%ADs%20Vasco%20y%20Navarra&body=https://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-S1695403302779319", "/es-exportar-rif-S1695403302779319", "http://www.mendeley.com/import/?url=http://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-resumen-S1695403302779319", "/es-estadisticas-S1695403302779319", "https://plu.mx/plum/a/?doi=10.1016/S1695-4033(02)77931-9", "/es-abordaje-terapeutico-otitis-media-aguda-articulo-S1695403321000138", "/es-caracteristicas-pacientes-con-enfermedad-neumococica-articulo-S1695403320301429", "/es-enfermedad-neumococica-invasiva-ninos-menores-articulo-S169540332100206X", "http://www.aeped.es/", "/es-guia-autores", "/es-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/es-diversity-pledge", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/c_i_es.pdf", "https://www.icmje.org/recommendations/", "/es-ahead-of-print", "/", "/es-mas-leidos", "/es-numeros-anteriores", "/es-suplementos", "/es-guia-autores", "/es-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/es-diversity-pledge", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/c_i_es.pdf", "/es-comite-editorial", "/es-permisos-reproduccion", "https://www.elsevier.com/legal/elsevier-website-terms-and-conditions", "https://www.elsevier.com/legal/privacy-policy-es-es", "/es-contratar", "https://tienda.elsevier.es/anales-de-pediatria-16954033.html", "/es-alerta-email", "/es-rss-ultimo", "/es-contratar", "/es-contacto", "/es-comite-editorial", null, "/es", "/en", "/es", "/es-ahead-of-print", "/es-vol-99-num-3-sumario-S1695403323X00071", "/es-numeros-anteriores", "/es-suplementos", "/es-alerta-email", "/es-guia-autores", "/es-envio-manuscritos", "https://www.elsevier.com/editors/perk", "/es-diversity-pledge", "https://static.elsevier.es/assets_org_prod/webs/42/pdf/c_i_es.pdf", "/es-acerca-revista", "/es-comite-editorial", "https://tienda.elsevier.es/anales-de-pediatria-16954033.html", "mailto:analespediatria@elsevier.com", "/es-contratar", "/es-mas-leidos", "/es-mas-citado", "/es-mas-populares", "/es-metricas", "/index.php?p=revista&tipo=pdf-simple&pii=S1695403302779319&r=37", "#bibliografia", "javascript:imprimirItem()", "mailto:?subject=Recomendaci%C3%B3n%20de%20lectura%20%20Estudio%20de%20la%20incidencia%20de%20enfermedad%20neumoc%C3%B3cica%20invasora%20entre%200%E2%80%935%20a%C3%B1os%20en%20el%20Pa%C3%ADs%20Vasco%20y%20Navarra&body=https://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-S1695403302779319", "/es-exportar-rif-S1695403302779319", "http://www.mendeley.com/import/?url=http://www.analesdepediatria.org/es-estudio-incidencia-enfermedad-neumococica-invasora-articulo-resumen-S1695403302779319", "/es-estadisticas-S1695403302779319", "https://plu.mx/plum/a/?doi=10.1016/S1695-4033(02)77931-9"]}